Total Syntheses and Biological Evaluation of the Ganoderma Lucidum Alkaloids Lucidimines B and C

Summary

This research examined compounds called lucidimines found in the medicinal mushroom Ganoderma lucidum, commonly known as Reishi. Scientists created synthetic versions of these compounds and tested their potential health benefits. The study found that one compound (lucidimine B) showed promising antioxidant properties and ability to slow the growth of breast cancer cells in laboratory tests. Impacts on everyday life: – Provides scientific evidence supporting traditional use of Reishi mushroom supplements – Identifies specific compounds that may contribute to Reishi’s health benefits – Opens possibilities for developing new natural-based medicines – Helps validate quality standards for Reishi mushroom products – Advances understanding of how mushroom compounds may fight cancer

Background

Ganoderma lucidum is an important medicinal mushroom used extensively in Asia to improve well-being and promote good health. While various compounds have been isolated from G. lucidum, the biological properties of its alkaloid constituents remain unknown. This study focuses on synthesizing and evaluating lucidimines B and C, key members of the first family of alkaloids isolated from G. lucidum.

Objective

To achieve the first total syntheses of lucidimines B and C and evaluate their biological properties as antioxidants and antiproliferative agents against cancer cells. The study aimed to demonstrate the potential contribution of alkaloidal constituents to the beneficial health claims made for G. lucidum as a nutraceutical.

Results

Lucidimine B showed superior antioxidant activity compared to lucidimine C across all assays. For antiproliferative effects, lucidimine B exhibited significant activity against MCF-7 cells with an EC50 value of 0.27 ± 0.02 μmol/mL, while lucidimine C was inactive. Mechanistic studies revealed that lucidimine B induced cell cycle arrest in the S phase, triggered DNA fragmentation, and reduced mitochondrial membrane potential in MCF-7 cells.

Conclusion

The study successfully achieved the first total syntheses of lucidimines B and C and demonstrated that alkaloid components from G. lucidum possess valuable yet previously underestimated antioxidant and antiproliferative properties. The findings provide scientific evidence supporting the health claims of G. lucidum as a nutraceutical.
Scroll to Top